Financial Conflict of Interest Policy

Aridis Logo

In compliance with federal regulations Aridis  Pharmaceuticals requires Principal Investigators and other key personnel on a  sponsored project to disclose a list of Significant Financial Interests (and  those of his/her spouse and dependent children) that could be reasonably  expected to bias the design, conduct, or reporting of the project. PIs,  Co-PIs, and in some instances, key personnel listed on a proposal for  external funding must complete a Financial Conflict of Interest disclosure  form (by completing the Aridis Financial Conflict of Interest form) before  submitting a proposal to and expending resources on a sponsored project  funded by PHS (NIH, BARDA), NSF or other agencies adopting federal  requirements.


NEW federal regulations regarding financial conflict of  interest (FCOI) have been issued by the Department of Health and Human  Services and went into effect August 24, 2012.


The new regulations can be found here:

The Aridis Financial Conflict of Interest Policy can be found here : Aridis FCOI Research Policy 2011.pdf  (Available to public)

Aridis FCOI Disclosure Form can be found here:  Aridis FCOI_Disclosure Form.pdf  (Available to Aridis employees)


NIH Conflict of Interest Tutorial

Investigators are required to complete mandatory training  before engaging in research funding by PHS. NIH has developed a web-based  tutorial that addresses the main requirements of the revised regulation. The  tutorial highlights the key Federal requirements for which the Investigator,  Aridis Pharmaceuticals, and NIH or other PHS-Funded agencies are accountable  under the new regulation.


For more information, visit the following links:

  42 CFR Part 50, 45 CFR Part 94



  NIH FCOI Tutorial



If you have any remaining questions about the Financial Conflict of Interest  Policy or regarding completing the FCOI forms, please contact the designated  Sponsored Programs Official.